Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicenter, Double-Blind Study of the Safety and Efficacy of Bio-E-Gel (Topical Estradiol Gel) Versus Placebo for Treatment of Vasomotor Symptoms and Vulvovaginal Atrophy in Postmenopausal Females

NCT00391417 is registered in ClinicalTrials.gov with BioSante Pharmaceuticals as lead sponsor.

NCT NCT00391417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00391417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicenter, Double-Blind Study of the Safety and Efficacy of Bio-E-Gel (Topical Estradiol Gel) Versus Placebo for Treatment of Vasomotor Symptoms and Vulvovaginal Atrophy in Postmenopausal Females
Lead sponsor
BioSante Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
April 30, 2005
Enrollment
431
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hot flashes